The Joint Transnational Call for Proposals 2021, JPIAMR HARISSA
2024, Foreword
2024

The Joint Transnational Call for Proposals 2021, JPIAMR HARISSA

Foreword
Published March 27, 2024
Olga TAGADIUC
Nicolae Testemitanu State University of Medicine and Pharmacy, Republic of Moldova
pdf

Keywords

JPIAMR HARISSA
Program Initiative on Antimicrobial Resistance
Nicolae Testemitanu State University of Medicine and Pharmacy, Republic of Moldova

How to Cite

TAGADIUC, O. (2024) “The Joint Transnational Call for Proposals 2021, JPIAMR HARISSA”, One Health & Risk Management , pp. 10-11. Available at: https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/719 (Accessed: 2August2025).
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Joint programming (JP) has been a significant tool for planning and implementing research and development actions in Europe in this millennium. The European Union, along with its Member States and partners from associated and third countries, has endeavored to adopt a more coordinated approach to financing, planning, and implementing research and innovation activities through joint actions.

The Joint Program Initiative on Antimicrobial Resistance, JPIAMR, is an international collaborative platform involving 29 countries and the European Commission in the fight against antimicrobial resistance (AMR). JPIAMR coordinates national research funding and supports collaborative efforts to address AMR knowledge gaps from the One Health perspective. The JPIAMR program identifies key areas that require attention and provides guidance to countries, aiming to harmonize national and international AMR research programs to combat antimicrobial resistance globally. Aligned with the six strategic directions of the general research and innovation agenda of JPIAMR, the partnership engages in a wide range of activities with a One Health approach, seeking and supporting solutions to reduce the transmission of antimicrobial-resistant bacteria.

pdf

|Views: 155| |pdf Downloads: 55|


pdf
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Downloads

Download data is not yet available.

ANNOUNCEMENT

Starting from July 1, 2025, the article processing fee will be 20 EUR (or the equivalent in MDL at the official exchange rate of the National Bank of Moldova). The publication fee for an accepted article will be 150 EUR (or the equivalent in MDL).

Details here:

Processing Fee
A processing fee of 20 EUR (or the equivalent in MDL) will be charged for articles accepted for scientific review by the editorial committee of the One Health and Risk Management journal.
Note: This fee will only be charged if your article has been technically reviewed and accepted.

Publication Fee
Starting from 01.07.2025, a fee of 150 EUR (or the equivalent in MDL) will be charged for articles accepted for publication.
Additionally, authors will bear the cost of English language editing/translation services if the manuscript requires intervention. The fee is 5 EUR (or the equivalent in MDL) per page edited/translated.
The total cost for English editing/translation services will be communicated by the Editorial Board after the manuscript is accepted for publication.

Payment Details:
Payments should be made in MDL to the bank account opened in the name of the Biosafety and Biosecurity Association of the Republic of Moldova.
The invoice will be issued by the end of the month in which the payment was made.

Organization: Biosafety and Biosecurity Association of the Republic of Moldova
Address: 5C A. Cozmescu Street
Fiscal Code: 1017620004120
Bank Code (SWIFT): AGRNMD2X451
IBAN: MD34AG000000022513622370